Meta-analysis recapitulates data from 2023 - antibiotics prevent infection in patients with #AlcHep & steroids, but a mortality benefit remains out of reach. Do we need a larger study or are you using prophylactic antibiotics anyway? doi.org/10.1111/liv.16…

SAVE THE DATE! ❗ During #AlcoholAwarenessWeek, we're hosting a webinar exploring #AlcoholHarm in the #LGBTQI community We're keen to have LGBTQI community members & those working in alcohol services/commissioning present Find out more & sign up ⬇️ ow.ly/sQYZ50SqU04

Management of #AUD improves outcomes in #ALD. How can we deliver joint care and where are the knowledge gaps? See this expert review from Lorenzo Leggio DOI:10.1097/HEP.0000000000000996

We are thrilled to announce Prof. Vlad Ratziu as the new Editor-in-Chief of Journal of Hepatology, starting January 2025! Joining him: ➡️Deputy Editors: Annalisa Berzigotti & Frank Tacke ➡️Co-Editors: Tom H. Karlsen, Lorenza Rimassa, & Heiner Wedemeyer ➡️Senior Editor: Philip Newsome EASLnews

More evidence that screening for liver fibrosis can support positive behaviour change: more people remain abstinent after transient elastography. This lasts for at least six months after screening doi.org/10.1016/j.jhep…

We needed data to see how much alcohol can safely drink people living with metabolic syndrome. In a large Spain-USA collaborative study, we just showed that even small amounts of alcohol exacerbate liver fibrosis in people with MASLD. It's likely that the alcohol thresholds

This study addresses lifestyles and alcohol consumption and nicely illustrates the crossover of risk factors for steatotic liver disease - a reminder that we often have to address more than one cause of liver disease doi.org/10.1016/j.alco…

British Liver Trust roadshow in Leeds offering liver health checks and advice on liver health Forward Leeds EASLnews

📢Are you a clinician, public health expert or patient advocate? ❓Take 15 minutes to fill in the Digestive Cancers Europe Survey on HCC prevention and diagnosis! Help us to: 🟢Map the status quo in the prevention and diagnosis of HCC across the EU 🟢Assess stigma around HCC and liver

Harm reduction: adding non-alcoholic drink options in bars in the UK reduces overall alcohol consumption without reducing revenue doi.org/10.1111/add.16…

Read "Outcomes of patients with alcohol-associated hepatitis and acute kidney injury – Results from the HRS Harmony Consortium" at bit.ly/3Sa86qL #livertwitter

🚀 Exciting News! 🚀 The PHS-2024-2 SBIR & STTR Omnibuses are now live! 🌟 This is your chance to secure non-dilutive funding for your innovative research projects in alcohol use disorders. Apply today to join the forefront of scientific discovery bit.ly/2B8Dxgy

Save The Date! 📆 Have you been impacted by #Alcohol or #AlcoholHarm? We want to hear your views on a proposed #AlcoholHarm Prevention Levy & how monies raised could be spent Limited places available so sign up fast! eventbrite.co.uk/e/funding-alco…

Alcohol contributes to liver risk in all subtypes of #SLD Hepatology Communications doi.org/10.1016/j.jhep…

Poor diet and excess alcohol consumption interact to significantly increase the risk developing liver disease - think about more than 'just' alcohol nature.com/articles/s4146…

The risk of liver cancer in people with #ARLD cirrhosis is 2% over five years - but is associated with poor outcomes: 60% die within a yr of diagnosis. Better surveillance, better prevention, or both? @HepatoEpi Maja Thiele Ramon Bataller DOI: 10.14309/ajg.0000000000003077

SLD subtype classification varies over time based on alcohol consumption at given timepoints - but baseline alcohol consumption predicts outcomes. Previous alcohol consumption is important - but we need more information on the duration of this effect doi.org/10.1016/j.jhep…

GLP-1 analogues reduce risk of relapse to AUD in real world experience of large cohorts of people living with with obesity or diabetes Ramon Bataller Maja Thiele Novo Nordisk doi.org/10.1038/s41467…

October is #LiverCancer awareness month. One in twenty people with cirrhosis caused by #ArLD die from #LiverCancer after just five years of follow up but there is much still to learn about surveillance in this group doi.org/10.1016/j.jhep… European Liver Patients' Association EASLnews Digestive Cancers Europe